Search Results
Outcomes from ADAPT-HR-/HER2+ evaluating dual HER2 blockade
Dr. Kass Discusses HER2-Positive Breast Cancer Advancements
Treatment Options for HER2-Negative Breast Cancer
Dr. Mark Pegram on Combining Trastuzumab and Pertuzumab
HER2 Low Breast Cancer A New Therapeutic Subtype | 2023 KU Breast Cancer Year in Review Conference
DESTINY-Gastric03: trastuzumab deruxtecan in HER2-overexpressing gastric cancer
HER2 Heterogeneity and Neoadjuvant Therapy in Breast Cancer
Dr. Chavez Mac Gregor on Chemotherapy in Node-Positive HR+/HER2- Breast Cancer
Dr. Isaacs Discusses the Role of Neratinib in HER2+ Breast Cancer
Copy of Dr. Murthy on De-Escalation Strategies in HER2-Positive Breast Cancer
Optimizing Therapy in HER2+ Disease with Dr. Kevin Kalinsky
Anti-HER2 strategies in breast cancer: the ALTTO trial
